Marc Martinez-Llordella

Company: Quell Therapeutics

Job title: Co-founder & Vice President, Biology

Seminars:

Developing CAR-Treg Therapies to Enhance Clinical Efficacy 11:00 am

Discussing Treg engineering strategies to improve safety and efficacy Revealing insights into the ongoing LIBERATE clinical trial Exploring Treg stability and pharmacokinetics to enhance safetyRead more

day: Day 2 Treg Cell Therapy Track AM

Industry Leader’s Fireside Chat: Comparing Treg Cell Therapies & Treg Modulators as Effective Treatments for Inflammatory & Autoimmune Diseases 8:30 am

Exploring the effectiveness of treatment personalization to direct the future of Treg therapies Discussing technological challenges in Treg cell therapy or Treg modulator development Comparing Treg cell therapy and modulator treatment efficacy to identify enhancements to progress Treg therapiesRead more

day: Conference Day One AM